HWANG; Sun Gwan

Patent Applications and Registrations

Patent applications and USPTO patent grants for HWANG; Sun Gwan.The latest application filed is for "use of carbamate compound for preventing or treating trigeminal neuralgia".

Company Profile

5.11.14

HWANG; Sun Gwan - Gyeonggi-do KR
HWANG; Sun Gwan - Seongnam-si KR
Hwang; Sun Gwan - Daejeon N/A KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Carbamate Compound For Preventing Or Treating Trigeminal Neuralgia App 20220087976 - JO; Min Jae ; et al.	2022-03-24
Use of carbamate compound for preventing or treating trigeminal neuralgia Grant 11,207,295 - Jo , et al. December 28, 2	2021-12-28
Use Of Carbamate Compound For Preventing, Alleviating Or Treating Diabetic Peripheral Neuropathy Or Chemotherapy-induced Peripheral Neuropathy App 20210379018 - HWANG; Sun Gwan ; et al.	2021-12-09
Blend Containing Carbamate Compound For Prevention, Mitigation, Or Treatment Of Schizophrenia App 20210361622 - JOUNG; Chan Mi ; et al.	2021-11-25
Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease Grant 11,147,798 - Hwang , et al. October 19, 2	2021-10-19
Blend containing carbamate compound for prevention, mitigation, or treatment of schizophrenia Grant 11,116,751 - Joung , et al. September 14, 2	2021-09-14
Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia Grant 10,849,882 - Jo , et al. December 1, 2	2020-12-01
Blend Containing Carbamate Compound For Prevention, Mitigation, Or Treatment Of Schizophrenia App 20200281895 - JOUNG; Chan Mi ; et al.	2020-09-10
Use Of Carbamate Compound For Reducing Or Treating Developmental Disorders Including Fragile X Syndrome, Angelman Syndrome Or Re App 20200268711 - SHIN; Hye Won ; et al.	2020-08-27
Use Of Carbamate Compound For Prevention, Alleviation, Or Treatment Of Demyelinating Disease App 20190314338 - HWANG; Sun Gwan ; et al.	2019-10-17
Use Of Carbamate Compound For Preventing Or Treating Fibromyalgia Or Functional Syndrome Associated With Fibromyalgia App 20190298694 - JO; Min Jae ; et al.	2019-10-03
Use Of Carbamate Compound For Preventing Or Treating Trigeminal Neuralgia App 20190175555 - JO; Min Jae ; et al.	2019-06-13
Methylcyclohexane derivatives and uses thereof Grant 8,822,463 - Bae , et al. September 2, 2	2014-09-02
Pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives Grant 8,518,978 - Hwang , et al. August 27, 2	2013-08-27
Novel Methylcyclohexane Derivatives And Uses Thereof App 20130217686 - Bae; Sung Jin ; et al.	2013-08-22
Oxazole hydroxamic acid derivatives and use thereof Grant 8,039,634 - Cho , et al. October 18, 2	2011-10-18
Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate Grant 7,968,604 - Cho , et al. June 28, 2	2011-06-28
Isoxazole derivatives and use thereof Grant 7,915,297 - Cho , et al. March 29, 2	2011-03-29
Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives App 20110028506 - Hwang; Sun Gwan ; et al.	2011-02-03
Pharmaceutical Composition for Prevention and Treatment of Drug or Alcohol Addiction or Bipolar Disorder Using Sodium Phenylbutyrate App 20090221714 - Cho; Jeong-Woo ; et al.	2009-09-03
Oxazole Hydroxamic Acid Derivatives and Use Thereof App 20090209596 - Cho; Jeong-woo ; et al.	2009-08-20
Isoxazole Derivatives and Use Thereof App 20090131336 - Cho; Jeong Woo ; et al.	2009-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.